Amalgamated Bank’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $338K | Sell |
|
|||||
|
2025
Q2 | $316K | Hold |
|
|||||
|
2025
Q1 | $328K | Sell |
|
|||||
|
2024
Q4 | $255K | Sell |
|
|||||
|
2024
Q3 | $206K | Sell |
|
|||||
|
2024
Q2 | $406K | Sell |
|
|||||
|
2024
Q1 | $416K | Sell |
|
|||||
|
2023
Q4 | $673K | Sell |
|
|||||
|
2023
Q3 | $626K | Sell |
|
|||||
|
2023
Q2 | $837K | Buy |
|
|||||
|
2023
Q1 | $849K | Sell |
|
|||||
|
2022
Q4 | $862K | Sell |
|
|||||
|
2022
Q3 | $1.19M | Buy |
|
|||||
|
2022
Q2 | $1.27M | Sell |
|
|||||
|
2022
Q1 | $1.67M | Sell |
|
|||||
|
2021
Q4 | $1.38M | Sell |
|
|||||
|
2021
Q3 | $1.3M | Sell |
|
|||||
|
2021
Q2 | $1.43M | Buy |
|
|||||
|
2021
Q1 | $452K | Sell |
|
|||||
|
2020
Q4 | $421K | Buy |
|
|||||
|
2020
Q3 | $412K | Sell |
|
|||||
|
2020
Q2 | $366K | Sell |
|
|||||
|
2020
Q1 | $257K | Sell |
|
|||||
|
2019
Q4 | $359K | Buy |
|
|||||
|
2019
Q3 | $274K | Sell |
|
|||||
|
2019
Q2 | $317K | Buy |
|
|||||
|
2019
Q1 | $231K | Buy |
|
|||||
|
2018
Q4 | $251K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $244K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $240K | Buy |
|
|||||
|
2017
Q1 | $204K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $203K | Buy |
|
|||||
|
2015
Q4 | $269K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $267K | Buy |
|
|||||
|
2015
Q1 | $322K | Buy |
|
|||||
|
2014
Q4 | $309K | Buy |
|
|||||
|
2014
Q3 | $337K | Sell |
|
|||||
|
2014
Q2 | $320K | Buy |
|